lindas have a posse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If you disagree I don't care
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172073359
NWBO has an arsenal of angel investors who are committed to the endgame.
In 2019 NWBO had about 150 shareholders. They now have around 50K.
The market has spoken.
50K NWBO shareholders agree with my investment!
How many support the other side?
I feel great investing at the right time.
Regardless of what some may think NWBO are a trillion dollar company if they can execute on the greenfield all solid tumors market.
Keytruda serves less than 0.5% of all newly diagnosed cancer patients globally.
The numbers are astounding.
Like ATL says many times I don't care if you disagree but the numbers are not in dispute.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172073359
You can ignore the facts but the storage capacity for 50B in DCVax exists in Sawston UK only a single facility at 90K square feet.
How much can Merck store at Charles River Labs in Memphis?
200B?
500B?
FedEx global hub.
You will find out.
NWBO has storage capacity for 50 billion or so in DCVax doses at 200K per treatment plan. Your claims are false. Review PRs and ASCO presentations which contain facts.
50 billion of DCVax in cold storage @ Sawston disagrees with your flawed characterization.
Bring your own brain! He doesn't have one?
I agree Gary. They have more money to lose every day the pretrial motions proceed.
Intellectual property at risk during discovery. They will settle. Hundreds of billions at risk among all defendants, over time, if they lose their black edge from a closed discovery leak.
$1000 a share!
Exactly no way this will go to a jury trial in left wing NYC!
It's not gambling if you hold the Ace of Spades (NWBO shares)!
The judge has signaled that MTD will be denied.
MM might as well open their checkbook now instead of paying their legal council from now until September.
Nothing competes with DCVax that targets many hundreds of protein sites on the tumor. As somebody who claims to have a hard science background you should know that. Though I guess a social science layman like myself understands oncology more than the "jock!"
The prognosis for GBM has not changed. DCVax showed a clinicial benefit vs contemporaneous controls where patients all received the same standard of care. The results were super statistically significant with hazard ratios that showed the results were not random. We now know why thanks
to the immensely insightful Mechanism of Action presentation at ASCO 2023.
Celldex investors are in a far worse position than the holders of Northwest Biotherapeutics stock while I will wager the same goes for any other companies seeking to defeat heterogeneous cancers by targeting a single or only a few antigens. We target them all. Tumors cannot evade DCVax.
Great buy Gary. I am very happy with the 150K shares I added around 0.60.
Rindopepimut had national exposure as Adam Feuerstein was pumping Celldex but that didn't help their shareholders as their drug failed. As a result they had 15-1 reverse split in 2019. Zombieco since. Glad we are not in that position but on cusp of billions in revenue.
Rindopepimut looked promising in PII then failed PIII. Adam Feuerstein picked that over DCVax. He was wrong. You are wrong about this other treatment which, like Rindo, only targets one antigen. We target many hundreds of antigens. More shots on goal kill the heterogeneous GBM tumor.
Bridging studies are not comparatively complicated or time consuming given the company already has rigorous assays in place which ensure 98% vaccine potency.
There's absolutely not a trial needed with Flaskworks. We only need to create a vaccine from patient using clean room process as well as Flaskworks then use assays with methods such as protemoics, like we saw at ASCO 2023, to ensure vaccines have equivalent composition!
That's it. We already know how to do these studies. In fact the firm are doing this all the time internally, I guarantee, to validate that Flaskworks actually works. Handing over our internal data, in the format of a government report, as well as having more inspections isn't anything complicated as we've already done this with our existing GMP facility in the MIA license process.
Institutional Investors stay away because the stock has been under heavy manipulation for at least 5 years. Prerevenue biotechnology firms are risky. That will change though given the spoofing lawsuit as well as impending DCVax approval. In my opinion we will see dramatic reversal once the first approval occurs.
Nothing was post hoc.
Rindopepimut showed promise in Phase II. Adam Feuerstein promoted it over DCVax. It failed.
We could be bigger than Merck with a tissue agnostic global approval.
Cofer Black works behind the scenes. You don't see him coming. That's how spies and counterterrorism works, bro.
I wouldn't protest the additional revenue but it's not part of my investment thesis.
If I am paying $250K for a cancer cure I don't want to go to a retail store where some crack head happens to be buying swisher sweets.
Hospitals are not the most amazing places but I would imagine most patients would prefer to get the vaccine from their oncologist or in a private care facility not accessible to the general public.
Annie Post misconstrued the Walgreens VP prediction of DCVax approval in 2023 to meaning DCVax would be sold at retail locations like Walgreens. I also agree it's a ridiculous notion that will not happen.
NWBO will be worth hundreds of billions in the next decade either through independent or added market cap to the firm that buys DCVax. I don't care if you believe my predictions.
I am glad you support Linda Powers.
You don't know anything.
I trust in our CEO as do the majority of shareholders who voted for management at the last ASM.
https://www.c-span.org/video/?c5017935/user-clip-linda-powers-testifying-congress-july-17-1990
Linda Powers:
All very correct. The stakes are high so it behooves us to let management get it done. They seem to think that will occur this year given they're engaging in estate planning for this tax year.
You are simply wrong as every PR issued by the firm was a huge milestone.
The foundations of the next BP are being laid right now in my opinion.
You can be blind to the facts but that's your prerogative not any reflection on our world-class management.
Drug approval processes are not open, transparent, and full of disclosures. If you didn't know that already then maybe you should consider selling then buying QQQ.
Exercising warrants for shares creates a taxable event based upon strike price (price paid to company for each share) and the prevailing share price.
DCVax Direct trials were put on hold as were other for L.
During the NYAS presentation Dr Mulholland also said the GBM trial was paused because they ran out of money.
So I believe that manipulation for sure was a barrier to market entry.